APL
Company Details
Linkedin ID:
aurobindopharma
Website:
Employees number:
14,616
Number of followers:
309,342
NAICS:
3254
Industry Type:
Homepage:
aurobindo.com
IP Addresses:
0
Company ID:
AUR_4566535
Scan Status:
In-progress
AUROBINDO PHARMA LTD Company CyberSecurity Posture
aurobindo.com
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.
AUROBINDO PHARMA LTD A.I CyberSecurity Scoring
APL Risk Score (AI oriented)Between 750 and 799
APL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
APL Global Score (TPRM)XXXX
APL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
APL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
APL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for APL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2025.
Incident Types APL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2025.
Incident History — APL (X = Date, Y = Severity)
APL cyber incidents detection timeline including parent company and subsidiaries
APL Company Subsidiaries
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.
Loading...
APL Similar Companies
SUN PHARMA
Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro
Torrent Pharmaceuticals Ltd
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C
Cipla
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp
Alkem Laboratories Ltd.
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient,
PT Kalbe Farma, Tbk
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Zydus Group
The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl
CVS Pharmacy is America’s leading retail pharmacy with more than 9,600 locations nationwide. For more than 50 years, CVS Pharmacy has offered customers the products and services they need to stay on their path to better health. In addition to our pharmacies, our stores feature on-trend beauty depart
MACLEODS PHARMACEUTICALS LTD.
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
.png)
APL CyberSecurity News
August 20, 2025 07:00 AM
Microsoft limits Chinese firms' early access to cybersecurity flaw data
The announcement from Microsoft follows a campaign of cyberattacks that Microsoft blamed on state-sponsored hackers in China who targeted...
April 03, 2025 07:00 AM
BEL gains on bagging Rs 593-cr order from Indian Air Force
Bharat Electronics (BEL) added 1.40% to Rs 286.35 after the company has signed a contract with Indian Air Force (IAF) valued at Rs 593.22 crore.
March 03, 2025 08:00 AM
Cheapest pharma stocks in India
Pharma stocks are down, but is this a golden buying opportunity? With India's booming sector and low P/E stocks in focus, discover if these...
February 06, 2025 08:00 AM
Board of Orient Technologies approves acquisition of majority stake in eProtect 360 Solutions
At meeting held on 06 February 2025.
December 23, 2024 08:00 AM
Dev Information Technology soars 8% on launching new cybersecurity services
Shares of Dev Information Technology surged up to 7.76 per cent at Rs 163.80 a piece on the BSE in Monday's intraday trade.
December 23, 2024 08:00 AM
Shriram Finance shares rise 3% as Co fixes record date for stock-split
The uptick in Shriram Finance share price came after the company announced that it has fixed January 10, 2025 as the 'Record Date' for...
January 10, 2020 08:00 AM
Here's how Aurobindo Pharma adopted digital to streamline workforce
In an exclusive conversation with ETCIO, Gyan Pandey, Global and Group CIO, Aurobindo Pharma, highlights how going digital enabled the...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
APL CyberSecurity History Information
Official Website of AUROBINDO PHARMA LTD
The official website of AUROBINDO PHARMA LTD is https://www.aurobindo.com/.
AUROBINDO PHARMA LTD’s AI-Generated Cybersecurity Score
According to Rankiteo, AUROBINDO PHARMA LTD’s AI-generated cybersecurity score is 776, reflecting their Fair security posture.
How many security badges does AUROBINDO PHARMA LTD’ have ?
According to Rankiteo, AUROBINDO PHARMA LTD currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does AUROBINDO PHARMA LTD have SOC 2 Type 1 certification ?
According to Rankiteo, AUROBINDO PHARMA LTD is not certified under SOC 2 Type 1.
Does AUROBINDO PHARMA LTD have SOC 2 Type 2 certification ?
According to Rankiteo, AUROBINDO PHARMA LTD does not hold a SOC 2 Type 2 certification.
Does AUROBINDO PHARMA LTD comply with GDPR ?
According to Rankiteo, AUROBINDO PHARMA LTD is not listed as GDPR compliant.
Does AUROBINDO PHARMA LTD have PCI DSS certification ?
According to Rankiteo, AUROBINDO PHARMA LTD does not currently maintain PCI DSS compliance.
Does AUROBINDO PHARMA LTD comply with HIPAA ?
According to Rankiteo, AUROBINDO PHARMA LTD is not compliant with HIPAA regulations.
Does AUROBINDO PHARMA LTD have ISO 27001 certification ?
According to Rankiteo,AUROBINDO PHARMA LTD is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD employs approximately 14,616 people worldwide.
Subsidiaries Owned by AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD presently has no subsidiaries across any sectors.
AUROBINDO PHARMA LTD’s LinkedIn Followers
AUROBINDO PHARMA LTD’s official LinkedIn profile has approximately 309,342 followers.
NAICS Classification of AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
AUROBINDO PHARMA LTD’s Presence on Crunchbase
No, AUROBINDO PHARMA LTD does not have a profile on Crunchbase.
AUROBINDO PHARMA LTD’s Presence on LinkedIn
Yes, AUROBINDO PHARMA LTD maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/aurobindopharma.
Cybersecurity Incidents Involving AUROBINDO PHARMA LTD
As of December 22, 2025, Rankiteo reports that AUROBINDO PHARMA LTD has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
AUROBINDO PHARMA LTD has an estimated 5,459 peer or competitor companies worldwide.
AUROBINDO PHARMA LTD CyberSecurity History Information
How many cyber incidents has AUROBINDO PHARMA LTD faced ?
Total Incidents: According to Rankiteo, AUROBINDO PHARMA LTD has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at AUROBINDO PHARMA LTD ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md#reproduce
- https://vuldb.com/?ctiid.337689
- https://vuldb.com/?id.337689
- https://vuldb.com/?submit.719154
- https://www.tenda.com.cn/
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=aurobindopharma' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
